Eduardo Vega | Profiles RNS

Eduardo A. Vega, MD Hear my name

Assistant Professor

Boston University Chobanian & Avedisian School of Medicine

Surgery

MD, University of Los Andes

Websites

	AHPBA Podcast
	Google Scholar
	Boston University School of Medicine
	EAVegaMD
	MD Anderson Cancer Center

ORCID : 0000-0002-4643-0634

Dr. Vega, is a Hepato-Bilio-Pancreatic surgeon in the Department of Surgery at Saint Elizabeth Medical Center and Assistant Professor of Surgery BUSM. After completing residency in general surgery at Hospital Sotero del Rio, Santiago, Chile, Dr Vega served as Postdoctoral Fellow in the Department of Surgical Oncology at The University of Texas MD Anderson Cancer Center from 2017 to 2019. Later, Dr Vega moved to Boston, Massachusetts to complete a fellowship in Minimally Invasive Hepato-Pancreato-Biliary (HPB) Surgery at Saint Elizabeth’s Medical Center of Tufts University. This experience lead to multiple publications that found innovative prognostic solutions for gallbladder cancer and pancreatic cancer which are being applied to clinical practice at MD Anderson and in Chile today.
Dr. Vega’s current research focuses on novel techniques/technologies to treat complex liver and pancreas cancer. In this context, he designed multiple innovative techniques for HPB disease that use 3D reconstruction software. This work has produced multiple publications in Annals Surgical Oncology and other peer-review journals. This reciprocal relationship between clinical surgery and research is a primary focus for Dr. Vega’s with an ultimate goal of applying innovative solutions to healthcare needs, especially in geographic areas with limited health resources.
Dr. Vega is currently a member of several national and international organizations including The Society for Surgery of the Alimentary Tract, Society of American Gastrointestinal and Endoscopic Surgeons and a combined member of the International Hepato-Pancreato-Biliary Association and the Americas Hepato-Pancreato-Biliary Association. In the future, Dr. Vega hopes to remain active as both an academic clinical surgeon and a translational researcher.

Other Research

Title

International Collaborative Research Group of Gallbladder Cancer - Gallbladder adenocarcinoma (GBC) is a relatively rare malignancy with high mortality rate due to late-stage discovery. At advanced stages, there are limited treatment options, and most patients develop resistance to chemotherapy. In this study we combined data from Chile, Italy, USA, Japan, Colombia, Norway and Argentina to continue to answer the most important question in GBC. Our aim is to characterize tumor-associated immune cells and immune checkpoint markers and associate them with cancer genomic alterations, clinic-pathological information, and patient survival.
09/01/2021- (PI)

3D-Reconstruction using Artificial Intelligence - Despite the complexity of open and minimally invasive liver (HPB) surgery, practical intraoperative navigation systems are rare in clinical practice today. Combined HPB Surgery with 3D rendering and augmented reality could help to overcome the difficulties of open and laparoscopic HPB surgery in general (enhanced navigation in the three-dimensional space of the liver) and advanced laparoscopic liver surgery specifically. These issues are loss of depth perception, decreased spatial understanding and tactile feedback in the three-dimensional space of the liver, and complicated 3D anatomy without significant outward landmarks. The objective of the present study is to document, assess and analyze surgical cases performed in combination with 3D simulation software.
03/01/2019- (PI)

Management of Bleeding in laparoscopic HPB surgery - Despite the reported advantages of laparoscopic liver surgery and a wide-spread diffusion in Asia and Europe, advanced laparoscopic liver surgery remains practiced at few select institutions in the U.S. Data has shown that the main barrier to a broader acceptance is the concern for an uncontrollable intraoperative bleeding event. The aim of our innovation quality improvement and safety project with Prof. Gayet (IMM, Paris) is to develop an event-initiated checklist to optimize a team-based response to bleeding events. This checklist is akin to checklists in other industries with inherent risk for adverse events and high stress environments (e.g. military, flight industry). To illustrate how this innovative, event-triggered checklist concretely helps to optimize the response to a bleeding event, we have compiled cases into an educational video explaining each step of the simple 4-point checklist. Our aim is to organize team-based training of anesthesia and surgical staff with the checklist after systematic implementation to optimize the response to intraoperative bleeding events.
07/01/2018- (PI)

Yr	Title	Project-Sub Proj	Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Serenari M, Rivera B, Vega EA. Reply to the Letter to the Editor Regarding "Optimizing Outcomes in Gallbladder Cancer: Identifying Predictors of Futile Up-Front Surgery in a Global Multi-Center Study". Ann Surg Oncol. 2025 Apr 27. PMID: 40287892; DOI: 10.1245/s10434-025-17391-w;

Serenari M, Berti D, Rivera B, Newhook TE, Kristjanpoller W, Ruzzenente A, Okuno M, De Bellis M, Panettieri E, Ahmad MU, Merlo I, De Rose AM, Nishino H, Sinnamon AJ, Donadon M, Hauger MS, Guevara OM, Munoz C, Denbo J, Chun YS, Cao HST, Claria RS, Tzeng CD, de Aretxabala X, Vivanco M, Brudvik KW, Seo S, Pekolj J, Poultsides GA, Anaya DA, Torzilli G, Giuliante F, Guglielmi A, Vinuela E, Vauthey JN, Cescon M, Vega EA. ASO Visual Abstract: Optimizing Outcomes in Gallbladder Cancer: Identifying Predictors of Futile Up-Front Surgery in a Global Multi-Center Study. Ann Surg Oncol. 2025 Apr 01. PMID: 40167838; DOI: 10.1245/s10434-025-17216-w;

Serenari M, Rivera B, Kristjanpoller W, Vega EA. ASO Author Reflections: Surgical Wisdom in the Artificial Intelligence Era: Predicting Futility in Gallbladder Cancer. Ann Surg Oncol. 2025 Jun; 32(6):4431-4432. PMID: 40097797; DOI: 10.1245/s10434-025-17205-z;

Serenari M, Berti D, Rivera B, Newhook TE, Kristjanpoller W, Ruzzenente A, Okuno M, De Bellis M, Panettieri E, Ahmad MU, Merlo I, De Rose AM, Nishino H, Sinnamon AJ, Donadon M, Hauger MS, Guevara OM, Munoz C, Denbo J, Chun YS, Tran Cao HS, Sanchez Claria R, Tzeng CD, De Aretxabala X, Vivanco M, Brudvik KW, Seo S, Pekolj J, Poultsides GA, Anaya DA, Torzilli G, Giuliante F, Guglielmi A, Vinuela E, Vauthey JN, Cescon M, Vega EA. Optimizing Outcomes in Gallbladder Cancer: Identifying Predictors of Futile Up-Front Surgery in a Global Multi-center Study. Ann Surg Oncol. 2025 Jun; 32(6):4374-4382. PMID: 40050485; DOI: 10.1245/s10434-025-17083-5;

Kawahara W, Rivera B, Roberts J, Huang C, Ladu A, Sorescu GP, Rabkin DJ, Kozyreva O, Rotellar F, Vega EA. Laparoscopic left hemihepatectomy using the Arantius-first approach after 90Y transarterial radioembolization and immunotherapy in a cirrhotic patient. Br J Surg. 2025 Feb 01; 112(2).View Related Profiles.

Vega, Eduardo
Kozyreva, Olga

PMID: 39913344; DOI: 10.1093/bjs/znae305;

Mitri J, Ajjour S, Panettieri E, Naamani HE, Mahmood SK, Vega EA. Disparate Tumor Characteristics and Survival Outcomes Between Squamous Cell and Adenocarcinoma Subtypes in Cholangiocarcinoma. Ann Surg Oncol. 2024 Nov; 31(12):7688-7692.View Related Profiles.

Vega, Eduardo
Mahmood, Syed Kashif

PMID: 39251513; DOI: 10.1245/s10434-024-16118-7;

Salirrosas O, Vega EA, Chirban AM, Harandi H, Cohen M, Anderson A, Bhargava R, Conrad C. ASO Author Reflections: The More We See the More We are Capable of Seeing: Optimal Minimally Invasive Management of de Novo Pancreas Cancer After Prior Laparoscopic Whipple for Pancreas Cancer. Ann Surg Oncol. 2024 Oct; 31(10):7072-7073.View Related Profiles.